Ceftriaxon 1 g IV

Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic, indicated for:

• Respiratory tract infections (pneumonia, bronchitis)
• Urinary tract infections
• Skin and soft tissue infections
• Bone and joint infections
• Genital infections including Gonorrhea
• Intra-abdominal infections (in combination therapy)
• Septicemia
• Meningitis (as per physician’s guidance)
• Infection in Patients with impaired Defense mechanism
• Preoperative prophylaxix of infections.

General Adult Dosage:

• Typical dose: 1–2 g IV once daily (may be divided in severe infections)
• Severe infections: up to 4 g per day (divided doses)
• Duration: 5–14 days, depending on infection type and clinical response

Pediatric Dosage:

• Neonates & Infants (<2 months): 20–50 mg/kg/day in single or divided doses
• Children (2 months–12 years): 20–80 mg/kg/day in 1–2 divided doses (max 2 g/day)

Administration Notes:

• Reconstitute with sterile water or 0.9% sodium chloride as per instructions
• Administer slow IV injection (over 3–5 minutes) or IV infusion (30 minutes)
• Do not mix with calcium-containing IV solutions in neonates

Ceftriaxone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to:

• Disruption of cell wall formation
• Bacterial cell lysis
• Effective bactericidal activity against susceptible Gram-positive and Gram-negative bacteria

• Hypersensitivity:
• Known allergy to ceftriaxone, other cephalosporins, or beta-lactam antibiotics (e.g., penicillins).
• History of anaphylaxis or severe allergic reaction to any β-lactam drug.
• Neonates with hyperbilirubinemia:
• Newborns (≤28 days old) with jaundice or hyperbilirubinemia due to risk of bilirubin displacement and potential kernicterus.
• Concomitant use with IV calcium-containing solutions in neonates:
• Mixing ceftriaxone with calcium-containing IV fluids (e.g., Ringer’s, Hartmann’s) may cause precipitation in the lungs and kidneys, which can be fatal.
• Severe hepatic or renal impairment (caution in combination with above factors):
• Ceftriaxone is primarily excreted via bile and urine; severe dysfunction may require dose adjustment or alternative therapy.

• Use cautiously in patients with renal or hepatic impairment. Dose adjustment is required.
• Monitor for signs of superinfection (Candida or Clostridium difficile-associated diarrhea)
• Risk of hemolytic anemia or thrombocytopenia – monitor blood counts in prolonged therapy
• Avoid mixing with calcium-containing IV fluids in neonates (≤28 days): Monitor neonates for bilirubin levels to prevent kernicterus.

• Inform your doctor if you have a history of allergic reactions to penicillins, cephalosporins, or other β-lactam antibiotics.
• Prolonged use may lead to superinfection with non-susceptible organisms (e.g., Clostridium difficile).
• Monitor for persistent diarrhea or abdominal pain.
• Rarely, ceftriaxone may cause hemolytic anemia, leukopenia, or thrombocytopenia.
• Monitor complete blood counts during prolonged therapy.
• Drug Interactions :Calcium-containing solutions (Do not mix IV in neonates.) Anticoagulants( May alter prothrombin time; monitor if patient is on warfarin.).Aminoglycosides( Concomitant use may increase risk of nephrotoxicity.)
• In Pregnancy Use only if clearly needed and prescribed by a physician.
• Ceftriaxone passes into breast milk in small amounts; monitor the infant for adverse effects.
• Pain, redness, or swelling may occur. Rotate sites or dilute appropriately for infusion.

Common:

• Injection site reactions (pain, redness, swelling)
• Rash, urticaria
• Diarrhea, nausea, vomiting

Rare but serious:

• Severe allergic reactions: anaphylaxis, angioedema
• Clostridium difficile-associated diarrhea
• Hemolytic anemia, leukopenia, thrombocytopenia
• Liver enzyme elevation

Handling Side Effects:

• Mild GI upset: usually self-limiting
• Rash or hypersensitivity: stop drug and inform physician immediately
• Severe diarrhea or signs of infection: discontinue and seek urgent medical care

Allergic Reactions

Ceftriaxone, like other β-lactam antibiotics, may cause allergic reactions ranging from mild to life-threatening.

Signs and Symptoms:

Mild Reactions:

Rash or hives (urticaria), Itching, Redness or mild swelling at the injection site

Moderate Reactions:

Fever, Joint pain, Swelling of lips, face, or eyelids

Severe (Life-Threatening) Reactions – Anaphylaxis:

• Severe difficulty breathing or wheezing
• Swelling of tongue, throat, or mouth
• Rapid heartbeat, dizziness, or fainting
• Severe skin rash with blisters

Management of Allergic Reactions:

• Mild reactions:
  • Inform your healthcare provider immediately
  • Antihistamines may be prescribed
• Severe reactions / Anaphylaxis:
  • Stop ceftriaxone immediately
  • Administer epinephrine, corticosteroids, or antihistamines as directed by medical personnel
  • Provide emergency medical care

Precaution:

• Do not take ceftriaxone if you have a history of severe allergy to penicillin or cephalosporins without medical supervision.
• Always inform your doctor about any previous allergic reactions to medications.

• Store the dry powder at room temperature (15–25°C)
• Protect from moisture
• Use immediately after reconstitution or as per stability guidelines

Prescription-only medication. Ceftriaxone should be used only under medical supervision. The information provided here is for educational purposes and is not a substitute for professional medical advice. Improper use may result in allergic reactions, antibiotic resistance, or serious adverse effects. Always follow the prescribing doctor’s instructions.